About
Bond Biosciences is a clinical-stage biopharmaceutical company developing non-absorbed oral therapeutics that locally bind excess ions in the gastrointestinal tract to treat or prevent ion-related diseases such as iron overload caused by hereditary hemochromatosis.
Explore Bond Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.